Pulsed Field Ablation Market Report 2026

Pulsed Field Ablation Market Overview

• Pulsed Field Ablation market size has reached to $0.8 billion in 2025 • Expected to grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 24.4% • Growth Driver: Surge In Atrial Fibrillation Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden • Market Trend: Advancements In Targeted Cardiac Ablation Enhance Safety And Treatment Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pulsed Field Ablation Market?

Pulsed field ablation refers to a minimally invasive cardiac procedure that uses short bursts of high-voltage electrical pulses to selectively target and destroy heart tissue causing arrhythmias. This technology enables precise ablation with reduced damage to surrounding tissues compared to traditional methods. It is increasingly adopted for treating conditions like atrial fibrillation. The main components of pulsed field ablation include catheters and generators. Catheters refer to flexible, tube-shaped medical devices inserted into the body to deliver or remove fluids or to perform diagnostic and therapeutic procedures. The multiple indications are atrial fibrillation and non-atrial fibrillation. There are varied sources of ablation, such as pulsed field energy, pulsed field and radiofrequency energy, and pulsed field and cryoablation energy. The various application areas are ablation and ablation and mapping, and the key end uses are given to hospitals, cardiac catheterization labs, ambulatory surgical centers, and others.

What Is The Pulsed Field Ablation Market Growth Forecast?

The pulsed field ablation market size is expected to see exponential growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to growing geriatric population, increasing healthcare infrastructure in emerging markets, integration of AI in ablation procedures, rising preference for minimally invasive treatments, development of combination ablation energy sources. Major trends in the forecast period include minimally invasive cardiac procedures, patient-specific ablation planning, enhanced safety and reduced tissue damage, integration of imaging and mapping technologies, rapid adoption in electrophysiology labs.

Global Pulsed Field Ablation Market Segmentation

1) By Components: Catheters, Generators 2) By Indication: Atrial Fibrillation, Non-Atrial Fibrillation 3) By Source Of Ablation: Pulsed Field Energy, Pulsed Field And Radiofrequency Energy, Pulsed Field And Cryoablation Energy 4) By Application Area: Ablation, Ablation And Mapping 5) By End Use: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End Uses Subsegments: 1) By Catheters: Single-use Catheters, Reusable Catheters, Diagnostic Catheters, Therapeutic Catheters, Balloon Catheters, Mapping Catheters 2) By Generators: Monopolar Generators, Bipolar Generators, Pulsed Power Generators, Radiofrequency Generators With Pulsed Field Ablation Capability, Portable Generators, Fixed Or Stationary Generators

What Is The Driver Of The Pulsed Field Ablation Market?

The growing prevalence of atrial fibrillation is expected to propel the growth of the pulsed field ablation market going forward. Atrial fibrillation refers to an irregular and often rapid heart rhythm that can increase the risk of stroke and heart-related complications. The rise in prevalence of atrial fibrillation is due to the aging population, as older age significantly increases the risk of developing this heart rhythm disorder. Pulsed field ablation helps treat atrial fibrillation by using targeted electrical pulses to selectively destroy abnormal heart tissue, causing irregular rhythms, offering a faster, safer, and more precise alternative to traditional ablation methods. For instance, September 2024, according to the American Journal of Managed Care, a US-based peer review journal, recent estimates indicate that about 10.5 million U.S. adults, roughly 5% of the population, are living with atrial fibrillation (AF). Therefore, the growing prevalence of atrial fibrillation is driving the growth of the pulsed field ablation industry.

Key Players In The Global Pulsed Field Ablation Market

Major companies operating in the pulsed field ablation market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, AtriCure Inc., CardioFocus Inc., Galvanize Therapeutics Inc., Kardium Inc., Acutus Medical Inc., AtriAN Medical Ltd., Field Medical Inc., Thermedical Inc., Adagio Medical Inc., Arga Medtech Inc., Mirai Medical, Pulse Biosciences Inc., AccuPulse Medical Inc., Farapulse Inc., Biosense Webster Inc., CathRx Ltd., EP Solutions SA

Global Pulsed Field Ablation Market Trends and Insights

Major companies operating in the pulsed field ablation (PFA) market are focusing on technological innovations such as selective tissue ablation to enhance procedural safety and efficacy by minimizing damage to surrounding healthy tissues, reducing recovery times, and improving long-term treatment outcomes for patients with cardiac arrhythmias. Selective tissue ablation refers to the targeted destruction of specific diseased cells or tissues while preserving the surrounding healthy structures. For instance, in March 2025, Abbott, a US-based healthcare company, secured CE Mark approval for its Volt Pulsed Field Ablation System aimed at treating abnormal heart rhythms. This advanced system seamlessly integrates with Abbott's EnSite X electrophysiology platform, enhancing procedural visualization and navigation. The introduction of the Volt system represents a key advancement in electrophysiology technology. It delivers greater procedural efficiency, sharper imaging, and more accurate ablation for atrial fibrillation treatment. This next-generation device is poised to improve patient outcomes and streamline cardiac care.

What Are Latest Mergers And Acquisitions In The Pulsed Field Ablation Market?

In January 2024, CardioFocus, a US-based medical device firm, acquired the electrophysiology division of Galvanize Therapeutics to enhance its pulsed field ablation for an undisclosed amount. The acquisition includes the CE-marked CENTAURI System and the developmental QuickShot catheter. This move is intended to bolster CardioFocus’s presence in the electrophysiology market with both focal and single-shot PFA technologies. Galvanize Therapeutics is a US-based manufacturer and developer of the Aliya Pulsed Field Ablation (PFA) system.

Regional Outlook

North America was the largest region in the pulsed field ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pulsed Field Ablation Market?

The pulsed field ablation market consists of revenues earned by entities by providing services such as consultation and treatment planning services, remote monitoring and telehealth support, and device maintenance and calibration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pulsed field ablation market also includes sales of training simulators and educational tools and disposable consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.